"VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density

NCT ID: NCT00396994

Last Updated: 2013-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

174 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-02-28

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if daily low magnitude, high frequency whole body vibration can improve bone density in seniors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The treatment options for osteoporosis, a major health complication in the aged population, are limited to pharmacologic interventions, the majority of which are antiresorptive. Preliminary data demonstrate that high frequency, low magnitude mechanical stimulation (LMMS) can preserve bone mineral density (BMD) by preventing bone resorption due to disuse and aging, and can stimulate new bone formation.

To confirm and extend these observations, this study is a three-year, double-blind, randomized, placebo-controlled clinical trial of LMMS in 200 elderly women and men (60 years of age and older). A clinical center located in Boston, MA has recruited participants from multiple independent living facilities in close geographic proximity. Participants meeting the inclusion/exclusion criteria have been randomized to either brief daily exposure to LMMS on a vibrating platform or a placebo platform over a three year period. All participants receive 1000 mg of elemental calcium and 800 IU of vitamin D per day.

This study will provide new and important information about the role of low magnitude high frequency mechanical stimulation on the skeleton.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low magnitude mechanical stimulation

10 minutes per day of low magnitude mechanical stimulation using a vibrating platform set at 0.3 g and 30 Hz

Group Type EXPERIMENTAL

Low magnitude mechanical stimulation

Intervention Type DEVICE

10 minutes per day of low magnitude mechanical stimulation using a vibrating platform set at 0.3 g and 30 Hz

2

10 minutes per day standing on sham low mechanical stimulation platform

Group Type PLACEBO_COMPARATOR

Sham low magnitude mechanical stimulation

Intervention Type DEVICE

10 minutes per day of low magnitude mechanical stimulation using a sham vibrating platform

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low magnitude mechanical stimulation

10 minutes per day of low magnitude mechanical stimulation using a vibrating platform set at 0.3 g and 30 Hz

Intervention Type DEVICE

Sham low magnitude mechanical stimulation

10 minutes per day of low magnitude mechanical stimulation using a sham vibrating platform

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 60 years and over of all ethnic groups
* Weight less than 250 pounds
* Absence of terminal cancer or other illness necessitating hospice level services
* Capable of following the protocol and of understanding and providing informed consent
* Scoring less than 12 on the Short Blessed Test

Exclusion Criteria

* Immobilization of the axial or lower appendicular skeleton within the last year
* Nonambulatory (ambulation with an assistive device will be permitted)
* Malignancy other than cured thyroid cancer or skin cancer
* Hip replacement or internal fixation, total knee replacement, or lower limb fracture within the past year, or bilateral hip replacement
* Medications: glucocorticoids, suppressive doses of thyroid hormone as determined by screening TSH, anticonvulsant drugs (phenytoin, phenobarbital, carbamazepine), estrogen/testosterone replacement, selective estrogen receptor modulators (SERMs), PTH, or bisphosphonates more than 1 month in past year, calcitonin therapy within the preceding month, fluoride therapy at any time
* Paget's disease of bone, rheumatoid arthritis or other connective tissue disorders requiring systemic treatment with disease modifying drugs, or a history of Cushing's syndrome
* Fragility fracture within the past five years unless pharmacologic therapy not to be prescribed
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

Hebrew SeniorLife

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Douglas Kiel

Director Musculoskeletal Research Center

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Douglas P. Kiel, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Institute for Aging Research, Hebrew SeniorLife

Marian T. Hannan, DSc, MPH

Role: PRINCIPAL_INVESTIGATOR

Institute for Aging Research, Hebrew SeniorLife

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hebrew SeniorLife, Institute for Aging Research

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res. 2004 Mar;19(3):360-9. doi: 10.1359/JBMR.040129. Epub 2004 Jan 27.

Reference Type BACKGROUND
PMID: 15040823 (View on PubMed)

Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res. 2004 Mar;19(3):343-51. doi: 10.1359/JBMR.0301251. Epub 2003 Dec 22.

Reference Type BACKGROUND
PMID: 15040821 (View on PubMed)

Gilsanz V, Wren TA, Sanchez M, Dorey F, Judex S, Rubin C. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res. 2006 Sep;21(9):1464-74. doi: 10.1359/jbmr.060612.

Reference Type BACKGROUND
PMID: 16939405 (View on PubMed)

Kiel DP, Hannan MT, Barton BA, Bouxsein ML, Lang TF, Brown KM, Shane E, Magaziner J, Zimmerman S, Rubin CT. Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health. Clin Trials. 2010 Aug;7(4):354-67. doi: 10.1177/1740774510371014. Epub 2010 Jun 22.

Reference Type BACKGROUND
PMID: 20571129 (View on PubMed)

Muir JW, Kiel DP, Hannan M, Magaziner J, Rubin CT. Dynamic parameters of balance which correlate to elderly persons with a history of falls. PLoS One. 2013 Aug 5;8(8):e70566. doi: 10.1371/journal.pone.0070566. Print 2013.

Reference Type DERIVED
PMID: 23940592 (View on PubMed)

Jeffrey BA, Hannan MT, Quinn EK, Zimmerman S, Barton BA, Rubin CT, Kiel DP. Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: the VIBES study. BMC Med Res Methodol. 2012 Nov 14;12:171. doi: 10.1186/1471-2288-12-171.

Reference Type DERIVED
PMID: 23150931 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AG025489

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AG0071

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Whole Body Vibration in Middle Aged Men
NCT06644469 NOT_YET_RECRUITING NA
Effect of Electromyostimulation on Bone
NCT01296776 COMPLETED PHASE3